Transient CRISPR-Cas Delivery for Therapeutic Gene Editing in the Retina

被引：0
|
作者：
Botto, Catherine [1 ]
Pulman, Juliette [1 ]
Eriksson, Hanna [1 ]
Fradot, Valerie [1 ]
De Cian, Anne [2 ]
Concordet, Jean-Paul [2 ]
El-Amraoui, Aziz [3 ]
Dalkara, Deniz [1 ]
机构：
[1] Sorbonne Univ, CNRS, Inst Vis, INSERM, 17 Rue Moreau, F-75012 Paris, France
[2] Museum Natl Hist Nat, CNRS, UMR7196, INSERM,U1154, Paris, France
[3] Univ Paris, INSERM, Unit Progress Sensory Disorders Pathophysiol & Th, Inst Pasteur,Inst Audit,UMRS1120, 63 Rue Charenton, F-75012 Paris, France
来源：
MOLECULAR THERAPY | 2022年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
310
引用
收藏
页码：149 / 149
页数：1
相关论文
共 50 条
  • [31] Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9
    LaFountaine, Justin S.
    Fathe, Kristin
    Smyth, Hugh D. C.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 494 (01) : 180 - 194
  • [32] CRISPR-Cas gene editing technology and its application prospect in medicinal plants
    Guo, Miaoxian
    Chen, Hongyu
    Dong, Shuting
    Zhang, Zheng
    Luo, Hongmei
    [J]. CHINESE MEDICINE, 2022, 17 (01)
  • [33] CRISPR/Cas gene editing and delivery systems for cancer therapy
    Li, Yingjie
    Zhou, Shiyao
    Wu, Qinjie
    Gong, Changyang
    [J]. WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2024, 16 (01)
  • [34] Delivery and Application Progresses of CRISPR/Cas Gene Editing System
    Zhao Zi-Xuan
    Li Chun-Hui
    Zhou Li-Li
    Zhao De-Yao
    Weng Yu-Hua
    Xia Xin-Hua
    Huang Yuan-Yu
    [J]. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2020, 47 (04) : 286 - 299
  • [35] CRISPR-Cas Systems and Genome Editing: Beginning the Era of CRISPR/Cas Therapies for Humans
    Karpov, Dmitry S.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (10)
  • [36] A dual-specific CRISPR-Cas nanosystem for precision therapeutic editing of liver disorders
    Xu, Xiaojie
    Tang, Honglin
    Guo, Jiajing
    Xin, Huhu
    Ping, Yuan
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [37] A dual-specific CRISPR-Cas nanosystem for precision therapeutic editing of liver disorders
    Xiaojie Xu
    Honglin Tang
    Jiajing Guo
    Huhu Xin
    Yuan Ping
    [J]. Signal Transduction and Targeted Therapy, 7
  • [38] CRISPR-Cas systems for genome editing of mammalian cells
    Mani, Indra
    Arazoe, Takayuki
    Singh, Vijai
    [J]. REPROGRAMMING THE GENOME: CRISPR-CAS-BASED HUMAN DISEASE THERAPY, 2021, 181 : 15 - 30
  • [39] Simplified CRISPR-Cas genome editing for Saccharomyces cerevisiae
    Generoso, Wesley Cardoso
    Gottardi, Manuela
    Oreb, Mislay
    Boles, Eckhard
    [J]. JOURNAL OF MICROBIOLOGICAL METHODS, 2016, 127 : 203 - 205
  • [40] Improvements in the genetic editing technologies: CRISPR-Cas and beyond
    Mingarro, Gerard
    li del Olmo, Marcel
    [J]. GENE, 2023, 852
12345